These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 1824742)

  • 1. Protamine-heparin-induced pulmonary hypertension in pigs: effects of treatment with a thromboxane receptor antagonist on hemodynamics and coagulation.
    Nuttall GA; Murray MJ; Bowie EJ
    Anesthesiology; 1991 Jan; 74(1):138-45. PubMed ID: 1824742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protamine-induced pulmonary hypertension in heparinized monkeys and pigs is inhibited by the thromboxane receptor antagonist SQ 30,741.
    Schumacher WA; Heran CL; Ogletree ML
    Eicosanoids; 1990; 3(2):87-93. PubMed ID: 2144979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboxane mediation of pulmonary hemodynamic responses after neutralization of heparin by protamine in pigs.
    Conzen PF; Habazettl H; Gutmann R; Hobbhahn J; Goetz AE; Peter K; Brendel W
    Anesth Analg; 1989 Jan; 68(1):25-31. PubMed ID: 2910134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of BM-573 [N-terbutyl-N'-[2-(4'-methylphenylamino)-5-nitro-benzenesulfonyl]urea], a dual thromboxane synthase inhibitor and thromboxane receptor antagonist, in a porcine model of acute pulmonary embolism.
    Ghuysen A; Lambermont B; Dogné JM; Kolh P; Tchana-Sato V; Morimont P; Magis D; Hanson J; Segers P; D'Orio V
    J Pharmacol Exp Ther; 2004 Sep; 310(3):964-72. PubMed ID: 15121765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward a better understanding of the hemodynamic effects of protamine and heparin interaction.
    Stefaniszyn HJ; Novick RJ; Salerno TA
    J Thorac Cardiovasc Surg; 1984 May; 87(5):678-86. PubMed ID: 6717047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass.
    Tao W; Deyo DJ; Brunston RL; Vertrees RA; Grochoske TL; Zwischenberger JB
    ASAIO J; 1997; 43(5):M825-30. PubMed ID: 9360162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effect of cyclooxygenase inhibition on adverse hemodynamic responses after protamine.
    Hobbhahn J; Conzen PF; Zenker B; Goetz AE; Peter K; Brendel W
    Anesth Analg; 1988 Mar; 67(3):253-60. PubMed ID: 3125765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of the thromboxane receptor antagonist, sulotroban (BM 13.177; SK&F 95587), with streptokinase: demonstration of thrombolytic synergy.
    Kopia GA; Kopaciewicz LJ; Ohlstein EH; Horohonich S; Storer BL; Shebuski RJ
    J Pharmacol Exp Ther; 1989 Sep; 250(3):887-95. PubMed ID: 2528630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hemodynamic effects of intra-aortic versus intravenous administration of protamine for reversal of heparin in pigs.
    Rogers K; Milne B; Salerno TA
    J Thorac Cardiovasc Surg; 1983 Jun; 85(6):851-5. PubMed ID: 6855256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil activation mediates protamine-induced pulmonary hypertension.
    Cho PW; Gillinov AM; Zehr KJ; Burch RM; Winkelstein JA; Cameron DE
    J Surg Res; 1993 May; 54(5):486-93. PubMed ID: 8103132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-protamine complexes cause pulmonary hypertension in goats.
    Horiguchi T; Enzan K; Mitsuhata H; Murata M; Suzuki M
    Anesthesiology; 1995 Oct; 83(4):786-91. PubMed ID: 7574058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of BAY 41-2272 in the pulmonary hypertension induced by heparin-protamine complex in anaesthetized dogs.
    Freitas CF; Morganti RP; Annichino-Bizzacchi JM; De Nucci G; Antunes E
    Clin Exp Pharmacol Physiol; 2007; 34(1-2):10-4. PubMed ID: 17201729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse cardiopulmonary effects and increased plasma thromboxane concentrations following the neutralization of heparin with protamine in awake sheep are infusion rate-dependent.
    Morel DR; Costabella PM; Pittet JF
    Anesthesiology; 1990 Sep; 73(3):415-24. PubMed ID: 2098007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of protamine sulfate are dependent on the presence and type of circulating heparin.
    Fiser WP; Fewell JE; Hill DE; Barnes RW; Read RC
    J Thorac Cardiovasc Surg; 1985 Jan; 89(1):63-70. PubMed ID: 3965817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet factor 4 injection produces acute pulmonary hypertension in the awake lamb.
    Kurrek MM; Winkler M; Robinson DR; Zapol WM
    Anesthesiology; 1995 Jan; 82(1):183-7; discussion 31A. PubMed ID: 7832299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of leukopenia on pulmonary hypertension after heparin-protamine in pigs.
    Habazettl H; Conzen PF; Vollmar B; Yekebas E; Peter K
    J Appl Physiol (1985); 1992 Jul; 73(1):44-9. PubMed ID: 1506397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboxane receptor blockade prevents pulmonary hypertension induced by heparin-protamine reactions in awake sheep.
    Montalescot G; Lowenstein E; Ogletree ML; Greene EM; Robinson DR; Hartl K; Zapol WM
    Circulation; 1990 Nov; 82(5):1765-77. PubMed ID: 2146041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depressed cardiovascular function and altered platelet kinetics following protamine sulfate reversal of heparin activity.
    Wakefield TW; Whitehouse WM; Stanley JC
    J Vasc Surg; 1984 Mar; 1(2):346-55. PubMed ID: 6481883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and toxicity of differently charged polycationic protamine-like peptides for heparin anticoagulation reversal.
    DeLucia A; Wakefield TW; Andrews PC; Nichol BJ; Kadell AM; Wrobleski SK; Downing LJ; Stanley JC
    J Vasc Surg; 1993 Jul; 18(1):49-58; discussion 58-60. PubMed ID: 8326659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary hypertension after heparin-protamine: roles of left-sided infusion, histamine, and platelet-activating factor.
    Habazettl H; Conzen PF; Vollmar B; Yekebas E; Gutmann R; Hobbhahn J; Brendel W; Peter K
    Anesth Analg; 1990 Dec; 71(6):637-44. PubMed ID: 2240637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.